Company Overview of SV Life Sciences Advisers, LLC
SV Life Sciences Advisers LLP is a private equity and venture capital firm specializing in all stages of development including seed, start-up, mid venture, early stage, expansion capital, growth capital, later stage, mature, PIPES, buyouts, turnarounds, middle market, and late venture investments. The firm seeks to invest in the human life sciences businesses with a focus on In Vitro Diagnostics, post-acute care delivery, biotechnology, medical devices and instrumentation, diagnostics, biopharmaceuticals, healthcare information technology, therapeutic protein and antibody, medical device research equipment, industry specific software, telecommunications, pharmaceutical services, media, comme...
One Boston Place
201 Washington Street
Boston, MA 02108
Founded in 1993
Key Executives for SV Life Sciences Advisers, LLC
Managing Partner and Chief Operating Officer
Compensation as of Fiscal Year 2014.
SV Life Sciences Advisers, LLC Key Developments
SV Life Sciences Advisers, LLC Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-10-2015 through Jan-11-2015
Dec 3 14
SV Life Sciences Advisers, LLC Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-10-2015 through Jan-11-2015. Venue: Four Seasons Hotel, 757 Market St, San Francisco, CA 94103, United States. Presentation Date & Speakers: Jan-11-2015, Kate Bingham, Managing Partner.
International Biotechnology Trust plc Approves Appointment of SV Life Sciences Managers LLP as its Alternative Investment Fund Manager with Effect from July 21, 2014
Jul 21 14
International Biotechnology Trust plc announced that it has entered into arrangements necessary to ensure compliance with the AIFMD. The company's Board of Directors approved the appointment of SV Life Sciences Managers LLP as the company's Alternative Investment Fund Manager ('AIFM') with effect from July 21, 2014, following the authorisation of SV Life Services Managers LLP as an AIFM by the UK's Financial Conduct Authority on July 16, 2014. The appointment is on the terms and subject to the conditions of an amended and restated investment management agreement with SV Life Sciences Managers LLP, the existing Investment Manager of the Company. The appointment is on the same commercial terms as the previous agreement but is also compliant with the new AIFMD regulatory regime. The arrangements in respect of the investment management and performance fee are unchanged. The AIFMD requires the Company to appoint a depositary (the "Depositary") and the Board has appointed HSBC Bank plc, the Company's existing Custodian, to act as the Company's Depositary. This appointment will take effect on 21 July 2014 on the terms and subject to the conditions of a depositary services agreement between the Depositary, the Company and SV Life Sciences Managers LLP. BNP Paribas Secretarial Services Limited will continue to act as company secretary to the Company.
Michael Balmuth Joins SV Life Sciences as Partner
Jul 8 14
SV Life Sciences announced the appointment of Michael Balmuth as Partner. Mr. Balmuth joins SVLS' Healthcare Services team, he will play a leading role in directing the firm's activities within the healthcare information technology (HCIT) sector while building on SVLS' past successes including investments in Homecare Homebase and Phase Forward. Before joining SVLS, Mr. Balmuth was a General Partner at Edison Ventures.
Similar Private Companies By Industry
Recent Private Companies Transactions